Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.

Preeclampsia (PE), is a serious pregnancy disorder characterized in the early gestation by shallow trophoblast invasion, impaired placental neo-angiogenesis, placental hypoxia and ischemia, which leads to maternal and fetal morbidity and mortality. Here we hypothesized that angiogenic sphingosine ki...

Full description

Bibliographic Details
Main Authors: Aneta Dobierzewska, Macarena Palominos, Marianela Sanchez, Michael Dyhr, Katja Helgert, Pia Venegas-Araneda, Stephen Tong, Sebastian E Illanes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4902228?pdf=render
_version_ 1818985490448121856
author Aneta Dobierzewska
Macarena Palominos
Marianela Sanchez
Michael Dyhr
Katja Helgert
Pia Venegas-Araneda
Stephen Tong
Sebastian E Illanes
author_facet Aneta Dobierzewska
Macarena Palominos
Marianela Sanchez
Michael Dyhr
Katja Helgert
Pia Venegas-Araneda
Stephen Tong
Sebastian E Illanes
author_sort Aneta Dobierzewska
collection DOAJ
description Preeclampsia (PE), is a serious pregnancy disorder characterized in the early gestation by shallow trophoblast invasion, impaired placental neo-angiogenesis, placental hypoxia and ischemia, which leads to maternal and fetal morbidity and mortality. Here we hypothesized that angiogenic sphingosine kinase-1 (SPHK1)/sphingosine-1-phosphate (S1P) receptors pathway is impaired in PE. We found that SPHK1 mRNA and protein expression are down-regulated in term placentae and term chorionic villous explants from patients with PE or severe PE (PES), compared with controls. Moreover, mRNA expression of angiogenic S1PR1 and S1PR3 receptors were decreased in placental samples of PE and PES patients, whereas anti-angiogenic S1PR2 was up-regulated in chorionic villous tissue of PES subjects, pointing to its potential atherogenic and inflammatory properties. Furthermore, in in vitro (JAR cells) and ex vivo (chorionic villous explants) models of placental hypoxia, SPHK1 mRNA and protein were strongly up-regulated under low oxygen tension (1% 02). In contrast, there was no change in SPHK1 expression under the conditions of placental physiological hypoxia (8% 02). In both models, nuclear protein levels of HIF1A were increased at 1% 02 during the time course, but there was no up-regulation at 8% 02, suggesting that SPHK1 and HIF1A might be the part of the same canonical pathway during hypoxia and that both contribute to placental neovascularization during early gestation. Taken together, this study suggest the SPHK1 pathway may play a role in the human early placentation process and may be involved in the pathogenesis of PE.
first_indexed 2024-12-20T18:35:44Z
format Article
id doaj.art-7278e9ecae18413ebf1ffe44fd9b7f28
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T18:35:44Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7278e9ecae18413ebf1ffe44fd9b7f282022-12-21T19:29:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015722110.1371/journal.pone.0157221Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.Aneta DobierzewskaMacarena PalominosMarianela SanchezMichael DyhrKatja HelgertPia Venegas-AranedaStephen TongSebastian E IllanesPreeclampsia (PE), is a serious pregnancy disorder characterized in the early gestation by shallow trophoblast invasion, impaired placental neo-angiogenesis, placental hypoxia and ischemia, which leads to maternal and fetal morbidity and mortality. Here we hypothesized that angiogenic sphingosine kinase-1 (SPHK1)/sphingosine-1-phosphate (S1P) receptors pathway is impaired in PE. We found that SPHK1 mRNA and protein expression are down-regulated in term placentae and term chorionic villous explants from patients with PE or severe PE (PES), compared with controls. Moreover, mRNA expression of angiogenic S1PR1 and S1PR3 receptors were decreased in placental samples of PE and PES patients, whereas anti-angiogenic S1PR2 was up-regulated in chorionic villous tissue of PES subjects, pointing to its potential atherogenic and inflammatory properties. Furthermore, in in vitro (JAR cells) and ex vivo (chorionic villous explants) models of placental hypoxia, SPHK1 mRNA and protein were strongly up-regulated under low oxygen tension (1% 02). In contrast, there was no change in SPHK1 expression under the conditions of placental physiological hypoxia (8% 02). In both models, nuclear protein levels of HIF1A were increased at 1% 02 during the time course, but there was no up-regulation at 8% 02, suggesting that SPHK1 and HIF1A might be the part of the same canonical pathway during hypoxia and that both contribute to placental neovascularization during early gestation. Taken together, this study suggest the SPHK1 pathway may play a role in the human early placentation process and may be involved in the pathogenesis of PE.http://europepmc.org/articles/PMC4902228?pdf=render
spellingShingle Aneta Dobierzewska
Macarena Palominos
Marianela Sanchez
Michael Dyhr
Katja Helgert
Pia Venegas-Araneda
Stephen Tong
Sebastian E Illanes
Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.
PLoS ONE
title Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.
title_full Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.
title_fullStr Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.
title_full_unstemmed Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.
title_short Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia.
title_sort impairment of angiogenic sphingosine kinase 1 sphingosine 1 phosphate receptors pathway in preeclampsia
url http://europepmc.org/articles/PMC4902228?pdf=render
work_keys_str_mv AT anetadobierzewska impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT macarenapalominos impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT marianelasanchez impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT michaeldyhr impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT katjahelgert impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT piavenegasaraneda impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT stephentong impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia
AT sebastianeillanes impairmentofangiogenicsphingosinekinase1sphingosine1phosphatereceptorspathwayinpreeclampsia